IDEXX Laboratories Inc
NASDAQ:IDXX
IDEXX Laboratories Inc
Gross Profit
IDEXX Laboratories Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Gross Profit
$2.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
11%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Gross Profit
$8.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Gross Profit
$10.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Gross Profit
$13.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Abbott Laboratories
NYSE:ABT
|
Gross Profit
$22.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Gross Profit
$4.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
See Also
What is IDEXX Laboratories Inc's Gross Profit?
Gross Profit
2.2B
USD
Based on the financial report for Mar 31, 2024, IDEXX Laboratories Inc's Gross Profit amounts to 2.2B USD.
What is IDEXX Laboratories Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
11%
Over the last year, the Gross Profit growth was 9%. The average annual Gross Profit growth rates for IDEXX Laboratories Inc have been 10% over the past three years , 12% over the past five years , and 11% over the past ten years .